Alan C. Sartorelli

Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells.

Beverly A. Teicher, John S. Lazo, Alan C. Sartorelli · PubMed · 1981 · 559 citations

Chemoprevention Strategy, Pathology, Pharmacotherapy +18

Choroid plexus epithelial expression of <i>MDR</i> <i>1</i> P glycoprotein and multidrug resistance-associated protein contribute to the blood–cerebrospinal-fluid drug-permeability barrier

V. Venkat Rao, Julie L. Dahlheimer, Mark E. Bardgett et al. · Proceedings of the National Academy of Sciences · 1999 · 525 citations · Full text

Cellular Pharmacology, Cellular Physiology, Drug Resistance +16

The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes

Davide F. Robbiani, Rick A. Finch, Dirk Jäger et al. · Cell · 2000 · 455 citations · Full text

Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity

Rick A. Finch, Mao-Chin Liu, Susan P. Grill et al. · Biochemical Pharmacology · 2000 · 363 citations

Medicinal Chemistry, Biochemistry, 3-Aminopyridine-2-carboxaldehyde- Thiosemicarbazone +12

Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins.

Germana Rappa, Aurelio Lorico, Richard A. Flavell et al. · PubMed · 1997 · 277 citations

Toxinology, Etoposide Levels, Lipid Peroxidation +19